gms | German Medical Science

64. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

26. - 29. Mai 2013, Düsseldorf

Surgical resection of brain metastases – impact on survival and neurological outcome

Meeting Abstract

  • Petra Schoedel - Klinik für Neurochirurgie, Universitätsklinikum Regensburg
  • Karl-Michael Schebesch - Klinik für Neurochirurgie, Universitätsklinikum Regensburg
  • Odo-Winfried Ullrich - Klinik für Neurochirurgie, Universitätsklinikum Regensburg
  • Alexander Brawanski - Klinik für Neurochirurgie, Universitätsklinikum Regensburg
  • Martin Andreas Proescholdt - Klinik für Neurochirurgie, Universitätsklinikum Regensburg

Deutsche Gesellschaft für Neurochirurgie. 64. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC). Düsseldorf, 26.-29.05.2013. Düsseldorf: German Medical Science GMS Publishing House; 2013. DocMI.05.07

doi: 10.3205/13dgnc319, urn:nbn:de:0183-13dgnc3191

Veröffentlicht: 21. Mai 2013

© 2013 Schoedel et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Objective: Brain metastases (BM) develop in about 40% of patients with cancer during the course of their disease. To select patients with the highest benefit from surgical resection, prognostic indices (RPA, GPA) have been formulated which are solely focussed on survival without considering neurological improvement. The goal of our study was to analyze the impact of surgical resection of BM on the neurological status in addition to overall survival in a large consecutive series of patients.

Method: We retrospectively analyzed 206 BM patients (female/male: 84/122) with a mean age of 61.1 years (range: 23.4–83.9). Exclusion criteria were biopsy only, histology other than metastasis and age younger than 18 years. Neurological deficits and quality of life and were quantified with the MRC-NPS and the Karnofsky score (KPS) respectively. In addition, signs of increased intracranial pressure (ICP), hemiparesis, visual deficits and aphasia were recorded preoperatively, at discharge and at follow-up.

Results: The most frequent primary cancer types were lung cancer (34%), malignant melanoma (14.5%), breast (13.6%) and colon cancer (9.7%). Gross total resection (GTR) was achieved in 92.2% of all patients. Only 9.7% of all patients were classified as RPA class I, 77.7% and 12.6% as RPA class II&III respectively. Surgical mortality and morbidity was 0.0% and 4.9% respectively. New neurologic deficits occurred in 6.3% of all patients. Local recurrence rate was 22.1%. The mean overall survival was 10.2 months. Multivariate analysis revealed poor RPA class and short time interval between diagnosis of cancer and the occurrence of BM as independent factors predictive for poor survival. Both, KPS and MRC-NPS improved significantly after resection, the highest improvement rate was recorded in patients presenting with increased ICP and hemiparesis. No significant improvement was achieved in visual deficits. Notably, the neurological benefits were independent of RPA class, 34.8% of RPA III patients improved to class II postoperatively.

Conclusions: Surgical resection leads to significant neurological improvement despite poor RPA class and short overall survival. Considering the low mortality and morbidity rates, resection should be considered as a valid option to increase neurological function and quality of life for patients with BM.